BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 7000236)

  • 1. Secondary prevention of myocardial infarction--the present state of the ART.
    Mitchell JR
    Br Med J; 1980 May; 280(6223):1128-30. PubMed ID: 7000236
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiplatelet drugs in the secondary prevention of myocardial infarction. One view of the present position.
    McNicol GP
    Lancet; 1980 Oct; 2(8197):736-8. PubMed ID: 6106840
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of drugs of platelets and complications of vascular disease.
    Mustard JF; Packham MA; Kinlough-Rathbone RL
    Adv Exp Med Biol; 1977; 82():94-105. PubMed ID: 920448
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of myocardial infarction by chemotherapy].
    Toshima H; Adachi K
    Nihon Rinsho; 1982; 40(11):2465-70. PubMed ID: 6130172
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: a difficult link.
    de Gaetano G; Cerletti C; Bertelè V
    Lancet; 1982 Oct; 2(8305):974-7. PubMed ID: 6127469
    [No Abstract]   [Full Text] [Related]  

  • 6. Myocardial infarction.
    Prentice CR
    Clin Haematol; 1981 Jun; 10(2):521-41. PubMed ID: 7032787
    [No Abstract]   [Full Text] [Related]  

  • 7. Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
    Hirsh J
    Arch Intern Med; 1981 Feb; 141(3 Spec No):311-5. PubMed ID: 7008733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet drugs after acute myocardial infarction.
    Mannucci PM
    Ric Clin Lab; 1984; 14(1):1-7. PubMed ID: 6729352
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticoagulants and platelet-active agents in the secondary prevention of coronary artery disease.
    Van Aken WG
    Adv Cardiol; 1982; 31():98-101. PubMed ID: 6758512
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trials in thrombosis: secondary prevention of myocardial infarction.
    Klimt CR; Doub PH; Doub NH
    Thromb Haemost; 1976 Feb; 35(1):49-56. PubMed ID: 785688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery.
    Cairns JA
    Cardiovasc Clin; 1987; 18(1):231-46. PubMed ID: 3300983
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood platelets and myocardial infarction].
    Musiał J; Dworski R; Szczeklik A
    Pol Tyg Lek; 1984 Dec; 39(50):1665-8. PubMed ID: 6396594
    [No Abstract]   [Full Text] [Related]  

  • 13. [Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
    Shalaev SV
    Kardiologiia; 1989 Sep; 29(9):116-20. PubMed ID: 2687554
    [No Abstract]   [Full Text] [Related]  

  • 14. [Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review].
    Verdecchia P
    G Ital Cardiol; 1982; 12(8):598-603. PubMed ID: 6762978
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiplatelet agents in prevention of myocardial infarction.
    Kshirsagar NA
    Indian Heart J; 1983; 35(1):60-6. PubMed ID: 6303947
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti platelet agents for strokes and myocardial infarction: a critical appraisal of recent clinical trials.
    Castaldi PA
    Aust N Z J Med; 1981 Dec; 11(6):673-7. PubMed ID: 7036973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
    Harker LA
    Circulation; 1986 Feb; 73(2):206-23. PubMed ID: 3510760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Present situation of therapy with platelet aggregation inhibitors].
    Poliwoda H
    Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antiplatelet drugs (author's transl)].
    Dechavanne M; Follea G; Trzeciak MC
    Anesth Analg (Paris); 1979; 36(7-8):283-7. PubMed ID: 525834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E.P.S.I.M., the French oral anticoagulant--aspirin trial in post-myocardial infarction patients: design, organization and quality control procedures.
    Boissel JP; Leizorovicz A; Schbath J; Destors JM; Gillet J
    Scand J Haematol Suppl; 1981; 38():47-72. PubMed ID: 7038857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.